Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol
Introduction Long-term population-based safety studies, applying advanced causal inference techniques, including an active comparator with new-user design, are needed to investigate skin cancer outcomes among individuals with multiple sclerosis (MS) treated with fingolimod. This study aims to descri...
Saved in:
Main Authors: | Lisa Kuramoto, Larry D Lynd, Amir Khakban, Jacquelyn J Cragg, Anthony Traboulsee, Jiwon Oh, Analisa Jia, Weng Sut Sio, M A De Vera, Jonathan Loree, Roger Tam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/1/e088924.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early Bilateral Cystoid Macular Oedema Secondary to Fingolimod in Multiple Sclerosis
by: Lei Liu, et al.
Published: (2012-01-01) -
Role of pattern and multifocal electroretinogram for macular evaluation in patients with multiple sclerosis treated with fingolimod
by: Randa H. Abdelgawad, et al.
Published: (2025-01-01) -
Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod
by: Tim Sinnecker, et al.
Published: (2016-01-01) -
Intermittent Atrioventricular Block following Fingolimod Initiation
by: E. Gialafos, et al.
Published: (2014-01-01) -
Livedo Reticularis in Association with Fingolimod: A Case Report
by: Elif Afacan Yıldırım, et al.
Published: (2024-01-01)